Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,346 | 77 | 95.4% |
| Education | $64.54 | 2 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $252.63 | 14 | $0 (2024) |
| PFIZER INC. | $206.36 | 9 | $0 (2020) |
| ABBVIE INC. | $120.25 | 8 | $0 (2024) |
| GlaxoSmithKline, LLC. | $117.26 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $100.53 | 6 | $0 (2024) |
| Lilly USA, LLC | $91.33 | 6 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $90.80 | 5 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $84.97 | 5 | $0 (2024) |
| Dexcom, Inc. | $64.17 | 2 | $0 (2024) |
| Exact Sciences Corporation | $50.23 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $339.37 | 18 | Dexcom, Inc. ($64.17) |
| 2023 | $130.67 | 9 | ABBVIE INC. ($41.92) |
| 2021 | $30.74 | 2 | Novo Nordisk Inc ($16.48) |
| 2020 | $73.73 | 5 | Novo Nordisk Inc ($25.90) |
| 2019 | $271.64 | 18 | SANOFI-AVENTIS U.S. LLC ($52.02) |
| 2018 | $429.13 | 21 | PFIZER INC. ($149.98) |
| 2017 | $135.12 | 6 | Novo Nordisk Inc ($77.67) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Endocrinology | ||||||
| 10/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Oncology | ||||||
| 08/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: RESPIRATORY | ||||||
| 07/24/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $44.31 | General |
| Category: Endocrinology | ||||||
| 07/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Oncology | ||||||
| 06/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Bone Health | ||||||
| 06/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.58 | General |
| 05/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Obesity | ||||||
| 04/10/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: RESPIRATORY | ||||||
| 03/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Diabetes | ||||||
| 03/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Respiratory | ||||||
| 01/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: NEUROSCIENCE | ||||||
| 01/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.13 | General |
| 01/17/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Diabetes | ||||||
| 12/12/2023 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Diabetes | ||||||
| 11/01/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.36 | General |
| 10/30/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,689 | 2,282 | $679,073 | $172,252 |
| 2022 | 18 | 1,791 | 2,472 | $678,622 | $167,306 |
| 2021 | 18 | 1,644 | 2,340 | $618,486 | $155,332 |
| 2020 | 21 | 1,554 | 2,148 | $536,217 | $117,306 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 418 | 762 | $281,940 | $62,869 | 22.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 336 | 336 | $133,392 | $41,093 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 289 | 465 | $117,645 | $27,062 | 23.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 58 | 58 | $63,510 | $16,321 | 25.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 156 | 156 | $34,164 | $11,211 | 32.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 157 | 157 | $8,949 | $4,792 | 53.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $16,269 | $2,739 | 16.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 58 | 58 | $3,306 | $1,770 | 53.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 21 | 21 | $3,150 | $1,056 | 33.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 68 | 92 | $3,680 | $875.84 | 23.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 20 | 22 | $4,422 | $860.86 | 19.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 19 | $2,926 | $805.22 | 27.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 50 | $3,450 | $432.96 | 12.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 26 | 26 | $1,898 | $260.16 | 13.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 26 | 31 | $372.00 | $105.71 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 444 | 817 | $302,290 | $64,167 | 21.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 305 | 305 | $121,085 | $38,081 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 312 | 509 | $128,777 | $30,307 | 23.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 142 | 142 | $31,098 | $9,733 | 31.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 25 | 25 | $27,375 | $6,951 | 25.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 145 | 145 | $8,265 | $4,263 | 51.6% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 21 | 21 | $7,581 | $2,792 | 36.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $15,147 | $2,479 | 16.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 41 | 46 | $7,084 | $1,721 | 24.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 51 | 51 | $2,907 | $1,512 | 52.0% |
About Dr. Neetu Reddy, MD
Dr. Neetu Reddy, MD is a Internal Medicine healthcare provider based in Jasper, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124062534.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Neetu Reddy, MD has received a total of $1,410 in payments from pharmaceutical and medical device companies, with $339.37 received in 2024. These payments were reported across 79 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,346).
As a Medicare-enrolled provider, Reddy has provided services to 6,678 Medicare beneficiaries, totaling 9,242 services with total Medicare billing of $612,196. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Jasper, GA
- Active Since 06/15/2006
- Last Updated 07/21/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1124062534
Products in Payments
- Saxenda (Drug) $118.43
- ELIQUIS (Drug) $114.08
- VRAYLAR (Drug) $91.70
- Ozempic (Drug) $88.67
- TOUJEO (Drug) $71.68
- FARXIGA (Drug) $66.15
- ANORO (Drug) $65.13
- Dexcom G6 Transmitter (Medical Supply) $64.17
- CHANTIX (Drug) $54.59
- Cologuard Collection Kit (Device) $50.23
- MOUNJARO (Drug) $45.07
- XARELTO (Drug) $42.22
- JARDIANCE (Drug) $32.33
- Wegovy (Drug) $32.17
- JANUVIA (Drug) $31.53
- AREXVY (Drug) $29.13
- Synthroid (Drug) $28.55
- Catheter - Arrow (Device) $26.38
- STIOLTO RESPIMAT (Drug) $23.98
- LYRICA (Drug) $23.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Jasper
Dr. Jordan Tate, M.d., Mph, M.D., MPH
Internal Medicine — Payments: $550,099
Dr. Sonja Pettus, M.d, M.D
Internal Medicine — Payments: $117,808
Syed Abbas Ali, Md, MD
Internal Medicine — Payments: $62,726
Michael Garcia, M.d, M.D
Internal Medicine — Payments: $24,692
Dr. Jerry Mosley, M.d, M.D
Internal Medicine — Payments: $20,340
Dr. Steve Johnson, M.d, M.D
Internal Medicine — Payments: $19,350